Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Antacid Market Size Worth $11,666.83 Million, Globally, by 2027 at 4% CAGR - Exclusive Report by The Insight Partners

This image opens in the lightbox

News provided by

The Insight Partners

15 Dec, 2021, 12:00 GMT

Share this article

Share toX

Share this article

Share toX

The Antacid Market Size is driven by increasing prevalence of gastroesophageal reflux disease (GERD), rising prevalence of obesity, rising prevalence of healthcare-associated infections and increasing emphasis on food safety. The tablet segment accounted for more than 59.57% of the market share in 2019 and anticipated to register the highest CAGR in the market during 2020-2027.

NEW YORK, Dec. 15, 2021 /PRNewswire/ -- According to the new market research report "Antacid Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Dosage Form (Tablet, Liquid, Others); Drug Class (Proton pump inhibitors, H2 Antagonist, Acid neutralizers); Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy) and Geography", published by The Insight Partners, the global antacid market is expected to reach US$ 11,666.83 million in 2027 from US$ 8,547.97 million in 2019. The market is estimated to grow with a CAGR of 4.0% from 2020-2027. Get the Latest COVID-19 Analysis on antacid market at https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00016359

Antacid Market: Competition Landscape and Key Developments

Sanofi, GlaxoSmithKline plc, Bayer AG, Takeda Pharmaceutical Company Limited, Sun Pharmaceuticals Ltd, Boehringer Ingelheim International Gmbh, Dr. Reddy's Laboratories Ltd., Pfizer, Inc, Reckitt Benckiser Group Plc., and Procter And Gamble are among the key companies operating in the antacid market. These players are focusing on the expansion and diversification of their market presence and the acquisition of a new customer base, thereby tapping prevailing business opportunities.

  • In August 2020, Takeda Pharmaceutical Company Limited declared that it has entered into an agreement to divest Takeda Consumer Healthcare Company Limited, a wholly-owned subsidiary of Takeda that operates in the consumer health care market primarily in Japan, to Oscar A-Co KK. This company is funded and managed by The Blackstone Group Inc..
  • In July 2016, Takeda Pharmaceutical Company Limited received FDA Approval for its antacid product Dexilant. It contains API dexlansoprazole. The product was approved  for patients of age group of 12-17 Years.
  • In December 2018, GSK and Pfizer entered a joint venture for consumer healthcare businesses. This transaction created a new world-leading Consumer Healthcare. This transaction is expected to close within three years of the closing of the transaction. This venture is expected to help the companies to lead the product categories in the respective markets. The types include Pain Relief, Respiratory, Vitamin and Mineral Supplements, Digestive Health, Skin Health, and Therapeutic Oral Health.

The North American region holds the largest market share of the market, whereas the Asia Pacific region is the fastest-growing region. The antacid market in North America is expected to grow due to the increasing incidence of GERD due to change in lifestyle, government support for prevention and treatment of gastrointestinal diseases, presence of well-developed healthcare infrastructure, growing pharmaceutical industry, reimbursement coverage and industry giants are some of the prominent factors propelling the market growth in North America. In US, growing prevalence of gastrointestinal diseases is likely to demand antacid drugs.

Get Exclusive Sample Pages of Antacid Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00016359/

As per the National Institute of Diabetes and Digestive and Kidney Diseases 2014 report, around 15 to 30% of the US population has GERD. Similarly, according to the National Health Interview Survey, 2018, about 14.8 million people in the US were diagnosed with ulcers. Furthermore, the National Ambulatory Medical Care Survey: 2016 reported that around 22.4 million number of visited physicians office for digestive diseases and about 8.3 million emergency department visits were for digestive diseases.

Also, product launches in the US is likely to favor the growth of the market. For instance, in October 2020, Dr. Reddy's Laboratories Ltd. launched the over-the-counter (OTC) Famotidine Tablets USP, 10 mg and 20 mg in the US market. These tablets are acid reducers that prevent and relieve heartburn associated with acid indigestion and sour stomach.

The Asia Pacific region is expected to be the fastest-growing region among all other regions. Increasing focus of market players on this region, and introduction of new products or therapies in the country. Moreover, rising prevalence of the gastrointestinal diseases, increase in healthcare spending and availability of advanced technology helps to boost the growth of antacid market in the region.

Rise in Prevalence of Gastroesophageal Reflux Disesae in Antacid Market:

Gastroesophageal reflux disease (GERD), a digestive disorder that affects the ring of muscle between esophagus and stomach, is a chronic and highly prevalent disorder. As per the report 'Update on the epidemiology of gastro-esophageal reflux disease: a systematic review' published in 2014, the prevalence of GERD is 18.1–27.8% in North America, 2.5–7.8% in East Asia, 8.8–25.9% in Europe, 8.7–33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America.

Furthermore, the National GI Survey was conducted and completed in 2015 and was the first major attempt to measure the prevalence of GERD in the US since 2005. As per the survey, 18% of the 71,000 people reported episodes of GERD twice a week and 31% reported GERD episodes once a week. The survey also reported that 35% of these patients used medications to control the condition and 55% of these used proton-pump inhibitors as their medication therapy. Additionally, the survey reported that the condition is more prevalent in women than in men. Thus, the factors mentioned above are driving the adoption of antacids during the forecast period.

Download Sample PDF Brochure of Antacid Market Size and Growth Research Report at https://www.theinsightpartners.com/sample/TIPRE00016359/

Antacid Market: Segmental Overview

Based on dosage form, is segmented into tablet, liquid, and others. The tablet segment accounted for more than 59.57% of the market share in 2019. In terms of drug class, is segmented into proton pump inhibitors, H2 antagonist, acid neutralizers. The proton pump inhibitors segment  held the largest share of the market in 2019. In terms of distribution channel, the antacid market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment held the largest share of the market in 2019.

The COVID-19 outbreak has disturbed various trades and businesses across the world. Several measures are being taken to treat the disease and prevent the transmission; however, the excessive number of COVID-19 cases has resulted in the doctor's appointment cancellation. With COVID-19 continuing to spread worldwide, researchers are looking into numerous options for possible treatment, including existing options such as OTC products for common diseases.

COVID-19 affected sales of the essential OTC drugs such as antacids. The companies are preferring non-physical marketing campaigns and shifting sales processes online. To support the nonprescription drug sale, For instance, in March 2020, American President signed into law the Coronavirus Aid Relief and Economic Security (CARES) Act (HR 748). This landmark legislation provides financial relief for workers, healthcare professionals, and small businesses affected by the coronavirus. Under the law, first, consumers will immediately benefit from purchasing OTCs with pre-tax Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA). OTC drugs, including nonprescription medications such as antacids, can again be purchased using tax-preferred funds by the nearly 60 million Americans enrolled in FSAs and HSAs. Moreover, the exports and imports of the pharmaceutical products is returning to its original momentum. Thus, the availability of the products in the region is improving. Therefore, the growth is likely to boost the development of the antacids market.

Buy Premium Copy of Antacid Market Size, Share, Revenue, Strategic Insights and Forecasts 2020-2027 Research Report at https://www.theinsightpartners.com/buy/TIPRE00016359/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com 
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/antacid-market
More Research: https://www.openpr.com/news/archive/139407/The-Insight-Partners.html

Logo: https://mma.prnewswire.com/media/1586348/The_Insight_Partners_Logo.jpg

Modal title

Also from this source

Leather for Automotive Seats Market Size Expected to Reach USD 69.12 Bn 2031, Growing at CAGR of 5.3%, Booming Automotive Industry Fuels Growth | The Insight Partners

Leather for Automotive Seats Market Size Expected to Reach USD 69.12 Bn 2031, Growing at CAGR of 5.3%, Booming Automotive Industry Fuels Growth | The Insight Partners

As per a new comprehensive report from The Insight Partners, the global leather for automotive seats market is observing significant growth owing to...

eSIM Market Size is Set to Achieve USD 17.98 Billion by 2031, With CAGR of 18.7% | The Insight Partners

eSIM Market Size is Set to Achieve USD 17.98 Billion by 2031, With CAGR of 18.7% | The Insight Partners

According to a new comprehensive report from The Insight Partners, the global eSIM market is observing significant growth owing to the rising...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.